SPI
17.391,52
PKT
-153,53
PKT
-0,88
%
Werbung
Analysen zu SPI-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 15.06.12 | UBS halten | Independent Research GmbH | |
| 15.06.12 | Emmi kaufen | Fuchsbriefe | |
| 15.06.12 | Barry Callebaut neutral | Sarasin Research | |
| 15.06.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 14.06.12 | ABB (Asea Brown Boveri) hold | Deutsche Bank AG | |
| 14.06.12 | Holcim overweight | Morgan Stanley | |
| 14.06.12 | Holcim buy | ING | |
| 14.06.12 | Swisscom neutral | Sarasin Research | |
| 14.06.12 | Holcim outperform | Cheuvreux SA | |
| 14.06.12 | Straumann underperform | Cheuvreux SA | |
| 14.06.12 | Holcim outperform | Cheuvreux SA | |
| 14.06.12 | Comet buy | Vontobel Research | |
| 14.06.12 | Barry Callebaut hold | Vontobel Research | |
| 14.06.12 | Holcim hold | Vontobel Research | |
| 14.06.12 | Schindler hold | Vontobel Research | |
| 14.06.12 | Arbonia hold | Vontobel Research | |
| 13.06.12 | UBS outperform | Credit Suisse Group | |
| 13.06.12 | Roche buy | Goldman Sachs Group Inc. | |
| 13.06.12 | Holcim neutral | J.P. Morgan Cazenove | |
| 13.06.12 | Zurich Insurance buy | Vontobel Research | |
| 13.06.12 | Holcim buy | Société Générale Group S.A. (SG) | |
| 13.06.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 13.06.12 | Swiss Re buy | Vontobel Research | |
| 13.06.12 | OC Oerlikon buy | Vontobel Research | |
| 13.06.12 | Vontobel reduce | Sarasin Research | |
| 12.06.12 | UBS neutral | UBS AG | |
| 12.06.12 | Julius Bär buy | UBS AG | |
| 12.06.12 | UBS sell | Société Générale Group S.A. (SG) | |
| 12.06.12 | Swiss Life buy | Nomura | |
| 12.06.12 | Basilea Pharmaceutica buy | Sarasin Research | |
| 12.06.12 | UBS hold | Société Générale Group S.A. (SG) | |
| 12.06.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 11.06.12 | Nestlé hold | Société Générale Group S.A. (SG) | |
| 11.06.12 | UBS hold | Commerzbank Corp. & Markets | |
| 11.06.12 | Barry Callebaut neutral | Sarasin Research | |
| 11.06.12 | Roche neutral | J.P. Morgan Cazenove | |
| 11.06.12 | Roche neutral | Nomura | |
| 11.06.12 | Barry Callebaut hold | Vontobel Research | |
| 11.06.12 | Novartis hold | Vontobel Research | |
| 08.06.12 | Novartis neutral | J.P. Morgan Cazenove |